相关实验视频

Updated: Jun 30, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

TSPO和配体在它们的结合过程中的相互和动态作用:PK-11195的一个例子

Rajas M Rao¹, Ibaa El Dhaybi², Frédéric Cadet³

¹Data Analytics, Bioinformatics and Structural Biology Division, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India; Université Paris Cité and Université de la Réunion and Université des Antilles, INSERM, BIGR, DSIMB UMR_S1134, F-74014, Paris, France.

|March 17, 2024

概括

分子动力学模拟显示,小鼠转位蛋白 (TSPO) 具有显著的灵活性. 与怀疑相反的NMR结构,即使具有连接体,也显示出动态行为,这表明它代表了一个有效的构造.

科学领域:

生物化学和分子生物学
结构生物学结构生物学
计算生物物理学的计算生物物理学

背景情况:

转位蛋白 (TSPO) 是一种18kDa的跨膜蛋白,对各种生理和病理生理过程至关重要.
对于TSPO结构的动态性质和构造景观,特别是鼠标TSPO NMR结构的理解有限.
TSPO在线粒体外膜上的定位强调了TSPO在细胞功能中的重要性.

研究的目的:

通过原子分子动力学模拟,彻底研究小鼠TSPO的动力学.
为了比较两个不同的起始结构的构造景观:一个NMR结构和一个同质模型 (HM).
评估诊断配体PKA对TSPO动态和两个结构的稳定性的影响.

主要方法:

用原子分子动力学模拟来研究小鼠TSPO.
模拟在诊断连接体PKA的存在和缺席下进行.
使用了两个初始结构,一种由NMR衍生的结构和一种基于细菌TSPO X射线结构的同质模型.

主要成果:

分子动力学模拟显示了小鼠TSPO蛋白的高全球灵活性.
基于NMR的模拟表明,即使连接了PKA连接体,也具有显著的灵活性.
相比之下,同质模型模拟显示灵活性降低,连接体表现出较低的稳定性和部分解结事件.

结论:

鼠标TSPO的NMR结构没有缺陷,但在蛋白质的全球构造空间中表现出一种独特的,灵活的构造.
联体的相互作用和稳定性根据开始的TSPO结构模型有很大的不同.
这些发现为TSPO的动态行为及其结构数据的解释提供了关键的见解.

关键词:

合规性分析是指对合规性的分析.符合形态空间的空间.体-受体相互作用的相互作用分子动力学分子动力学在 TSPO TSPO 中.

更多相关视频

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

相关概念视频

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Drug Distribution: Tissue Binding

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...

Tissue-Drug Binding: Localization of Drugs and its Significance

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...

Drug-Receptor Interactions

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....